
Muller & Phipps (India) is engaged in marketing of over the counter medical preparation and home care products.Product Profile: a) Cavisan - Medicated Dental Cream b) Cavifast - Medicated Dental Cream c) Cavisan - Gum Astringent d) Nixoderm
Muller and Phipps India Limited has announced the publication of its unaudited financial results for the quarter ended June 30, 2026. The company reported a total income of 203.33, alongside a net loss of 10.02 for the quarter. This translates to diluted earnings per share of 0.00. These financial figures...
Muller and Phipps India Limited has announced its 109th Annual General Meeting (AGM) will be held on September 28. For this meeting, a record date of September 18 has been set, meaning shareholders registered by then are eligible to participate. The company's Register of Members and Share Transfer Books will...